Learn More
Description
ADP affects platelet activation through its interaction with ADP receptors P2Y1, P2Y12 and P2X1. Upon its conversion to adenosine by ecto-ADPases, platelet activation is inhibited via adenosine receptors.
Specifications
Specifications
| Quantity | 500 mg |
| Optical Rotation | [α]20/D -29.6±1° c = 0.5% in 0.5M Na2HPO4 (Lit.) |
| Formula Weight | 471.2 |
| Percent Purity | ≥95% |
| Physical Form | Powder |
Safety and Handling
| Recommended Storage | Store at −20°C. |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.